NCT06290284

Brief Summary

The goal of this randomized controlled trial is to investigate the difference between LPC (mini-midline) and PIVC (peripheral venous catheter) on the need of further venipuncture for blood withdrawal or placement of a new vascular access. The main questions it aims to answer are:

  • Whether the number of patients with LPC and PIVC differ in terms of repeated venipunctures;
  • Whether the number of patients with LPC and PIVC differ in terms of adverse events associated with the use of such vascular catheters. Researchers will compare the proportion of patients with repeated venipunctures between LPC and PIVC arms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
294

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 25, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 17, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 31, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
Last Updated

March 4, 2024

Status Verified

March 1, 2024

Enrollment Period

2 months

First QC Date

January 31, 2024

Last Update Submit

March 1, 2024

Conditions

Keywords

Vascular accessEmergency DepartmentLong Peripheral CatheterPeripheral Intra-Venous Catheter

Outcome Measures

Primary Outcomes (1)

  • Difference in proportion

    Difference between the two study arms in the proportion of patients who required a venipuncture after insertion of the PIVC or the LPC.

    The catheter will be evaluated within 24 hours after the placement

Secondary Outcomes (1)

  • Adverse events associated with use of LPC and PIVC

    Adverse will be evaluated every 24 hours till the catheter removal

Study Arms (2)

Long Peripheral Catheter

EXPERIMENTAL

The procedure to place a LPC includes these steps: before inserting the catheter, the nurse will perform routine preliminary (non sterile) inspection of the arm to identify an insertion site. After selecting the insertion site, the nurse will release the tourniquet, with non-sterile gloves, and disinfect the skin around the insertion site. While allowing the antiseptic to act, the nurse will apply the tourniquet, and pull lightly with the thumb of the non-dominant hand to keep the vein from moving. After the needle has been inserted in the vein lumen, the guide wire is advanced and the catheter is inserted using the catheter wings. As the catheter is being inserted, the sheath (housing) is removed and then the wings. Before attaching the catheter to an extension without a needle or to a 3-way stopcock, it should be connected to a statlock to ensure it is safely fixated. A transparent, semi-permeable dressing will allow for daily visual inspection of the insertion site.

Procedure: Long Peripheral Catheter

Peripheral Intra-Venous Catheter

ACTIVE COMPARATOR

The procedure to place a PIVC includes these steps: before inserting the catheter, the nurse will perform routine preliminary (non sterile) inspection of the arm to identify an insertion site. After selecting the insertion site, the nurse will release the tourniquet, with non-sterile gloves, and disinfect the skin around the insertion site. While allowing the antiseptic to act, the nurse will apply the tourniquet, and pull lightly with the thumb of the non-dominant hand to keep the vein from moving. The needle will be inserted at a 10-30 degree angle about 1-2 cm distal from the catheter insertion site. Holding the needle firmly, the nurse will advance the cannula for its entire length into the lumen, remove the needle, and connect the cannula via an extension to a 3-way stopcock. A transparent, semi-permeable dressing will allow for daily visual inspection of the insertion site.

Procedure: Peripheral Intra-Venous Catheter

Interventions

PowerGlide Pro™ Midline Catheter

Long Peripheral Catheter

Venflon™ Pro Safety Needle Protected IntraVenous Cannula

Peripheral Intra-Venous Catheter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • High probability of hospital admission
  • Sufficient venous patrimony according to EA-DIVA scale score

You may not qualify if:

  • Patients already having a venous access in place
  • Patients requiring life-saving treatments
  • Patients seeking ambulatory care
  • Patients unable to express informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Milan, 20122, Italy

Location

Related Publications (2)

  • Civetta G, Cortesi S, Mancardi M, De Pirro A, Vischio M, Mazzocchi M, Scudeller L, Bottazzi A, Iotti GA, Palo A. EA-DIVA score (Enhanced Adult DIVA score): A new scale to predict difficult preoperative venous cannulation in adult surgical patients. J Vasc Access. 2019 May;20(3):281-289. doi: 10.1177/1129729818804994. Epub 2018 Oct 16.

    PMID: 30324841BACKGROUND
  • Binda F, Galazzi A, Marelli F, Salinaro G, de Vecchi M, Spagna S, Marcotullio A, Calegari J, Laquintana D, Gambazza S. Long versus conventional peripheral intravenous catheters to reduce venipunctures during hospital stay: A randomized controlled trial. J Vasc Access. 2025 Nov 3:11297298251385595. doi: 10.1177/11297298251385595. Online ahead of print.

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Alessandro Galazzi, PhD

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The statistician will be provided an anonymized dataset.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 31, 2024

First Posted

March 4, 2024

Study Start

September 25, 2023

Primary Completion

November 17, 2023

Study Completion

December 28, 2023

Last Updated

March 4, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations